(Q37981766)

26 August 2017

title

Remaining issues and challenges for rotavirus vaccine in preventing global childhood diarrheal morbidity and mortality (English)

1 reference

26 August 2017

1 reference

8

Umesh D Parashar

1 reference

26 August 2017

4

Benjamin A Lopman

1 reference

26 August 2017

1

Jacqueline E Tate

1 reference

26 August 2017

3

Margaret M Cortese

1 reference

26 August 2017

5

Jon R Gentsch

1 reference

26 August 2017

7

A Duncan Steele

1 reference

26 August 2017

Manish M Patel

2

1 reference

26 August 2017

Jessica Fleming

series ordinal

6

1 reference

26 August 2017

language of work or name

1 reference

1 February 2012

1 reference

Expert Review of Vaccines

26 August 2017

published in

1 reference

26 August 2017

volume

11

1 reference

26 August 2017

issue

2

1 reference

26 August 2017

page(s)

211-220

1 reference

Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine

26 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.184

Rotavirus and severe childhood diarrhea

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.184

Effect of rotavirus vaccination on death from childhood diarrhea in Mexico

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.184

Decline in diarrhea mortality and admissions after routine childhood rotavirus immunization in Brazil: a time-series analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.184

Decline in rotavirus hospitalizations and health care visits for childhood diarrhea following rotavirus vaccination in El Salvador

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.184

Impact of rotavirus vaccination on diarrhea-related hospitalizations among children < 5 years of age in Mexico.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.184

Reduction in pediatric rotavirus-related hospitalizations after universal rotavirus vaccination in Belgium

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.184

Herd immunity after two years of the universal mass vaccination program against rotavirus gastroenteritis in Austria

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.184

Reduction in acute gastroenteritis hospitalizations among US children after introduction of rotavirus vaccine: analysis of hospital discharge data from 18 US states

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.184

Diarrhea-associated hospitalizations among US children over 2 rotavirus seasons after vaccine introduction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.184

Comparison of 2 different regimens for reactogenicity, safety, and immunogenicity of the live attenuated oral rotavirus vaccine RIX4414 coadministered with oral polio vaccine in South African infants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.184

Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in sub-Saharan Africa: a randomised, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.184

Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in Asia: a randomised, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.184

Efficacy of the pentavalent rotavirus vaccine, RotaTeq®, in Finnish infants up to 3 years of age: the Finnish Extension Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.184

Association between pentavalent rotavirus vaccine and severe rotavirus diarrhea among children in Nicaragua

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.184

Trial of an attenuated bovine rotavirus vaccine (RIT 4237) in Gambian infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.184

Failure of live, attenuated oral rotavirus vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.184

Protection of Peruvian children against rotavirus diarrhea of specific serotypes by one, two, or three doses of the RIT 4237 attenuated bovine rotavirus vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.184

Evaluation of the efficacy of a low-passage bovine rotavirus (strain WC3) vaccine in children in Central Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.184

Safety and immunogenicity of single-dose live oral cholera vaccine CVD 103-HgR in 5-9-year-old Indonesian children

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.184

Co-administration study in South African infants of a live-attenuated oral human rotavirus vaccine (RIX4414) and poliovirus vaccines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.184

Supplementation with zinc, but not vitamin A, improves seroconversion to vibriocidal antibody in children given an oral cholera vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.184

Enhanced immunogenicity of an oral inactivated cholera vaccine in infants in Bangladesh obtained by zinc supplementation and by temporary withholding breast-feeding

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.184

Oral rotavirus vaccines: how well will they work where they are needed most?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.184

Inhibitory effect of breast milk on infectivity of live oral rotavirus vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.184

Influence of breast-feeding and oral poliovirus vaccine on the immunogenicity and efficacy of rotavirus vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.184

Comparative evaluation of safety and immunogenicity of two dosages of an oral live attenuated human rotavirus vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.184

Efficacy of pentavalent human-bovine (WC3) reassortant rotavirus vaccine based on breastfeeding frequency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.184

Sustained protection from pentavalent rotavirus vaccination during the second year of life at a large, urban United States pediatric hospital

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.184

Effectiveness of rotavirus vaccination against childhood diarrhoea in El Salvador: case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.184

Intussusception among infants given an oral rotavirus vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.184

Intussusception, rotavirus, and oral vaccines: summary of a workshop

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.184

Intussusception risk and health benefits of rotavirus vaccination in Mexico and Brazil

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.184

Real-time surveillance to assess risk of intussusception and other adverse events after pentavalent, bovine-derived rotavirus vaccine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.184

Validation of clinical case definition of acute intussusception in infants in Viet Nam and Australia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.184

Monovalent rotavirus vaccine provides protection against an emerging fully heterotypic G9P[4] rotavirus strain in Mexico

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.184

Broadening the age restriction for initiating rotavirus vaccination in regions with high rotavirus mortality: benefits of mortality reduction versus risk of fatal intussusception

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.184

Development of candidate rotavirus vaccines derived from neonatal strains in India

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.184

Complete genome sequence analysis of candidate human rotavirus vaccine strains RV3 and 116E

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.184

A dose-escalation safety and immunogenicity study of live attenuated oral rotavirus vaccine 116E in infants: a randomized, double-blind, placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.184

A hexavalent human rotavirus-bovine rotavirus (UK) reassortant vaccine designed for use in developing countries and delivered in a schedule with the potential to eliminate the risk of intussusception

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.184

Safety, efficacy, and immunogenicity of 2 doses of bovine-human (UK) and rhesus-rhesus-human rotavirus reassortant tetravalent vaccines in Finnish children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.184

Inactivated rotavirus vaccines: a priority for accelerated vaccine development

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.184

Intussusception following rotavirus vaccine administration: Post-marketing surveillance in the National Immunization Program in Australia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.184

Safety and Efficacy of an Attenuated Vaccine against Severe Rotavirus Gastroenteritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.184

Effect of Human Rotavirus Vaccine on Severe Diarrhea in African Infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.184

Effectiveness of Monovalent Rotavirus Vaccine (Rotarix) against Severe Diarrhea Caused by Serotypically Unrelated G2P[4] Strains in Brazil

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.184

Pentavalent Rotavirus Vaccine and Prevention of Gastroenteritis Hospitalizations in Australia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.184

Case-control evaluation of the effectiveness of the G1P[8] human rotavirus vaccine during an outbreak of rotavirus G2P[4] infection in central Australia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.184

21 January 2018

Identifiers

DOI

10.1586/ERV.11.184

1 reference

26 August 2017

1 reference